Elucidation of Analgesic Effects of Butorphanol Compared with Morphine: A Prospective Cohort Study

Rakesh Ranjan singh, Ashmita Kiran, Anant Narayan Sinha

Abstract


Pain is a complex subjective experience comprising of both physical and emotional components. The International Association for the Study of Pain defines pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of damage.”Opioids are essentially important constituent of balanced anaesthesia. They provide adequate analgesia, reduces requirement of inhaled anaesthetic agents, maintain cardiovascular stability and provide adequate post-operative analgesia. Morphine remains the most widely used analgesic and the gold standard against which all new opioids are compared. Butorphanol has been employed successfully for the relief of postoperative pain, labor pain, preanaesthetic medication and in balanced anaesthesia. We studied the analgesic property and the side effects of butorphanol and compared them with equipotent dose of morphine. This study revealed that butorphanol had more or less similar effects on haemodynamic parameters as compared to morphine. But butorphanol showed fewer side effects than morphine. This study suggested that patient compliance was on butorphanol.


Full Text:

PDF


DOI: https://doi.org/10.5296/jbls.v6i2.7524

Refbacks

  • There are currently no refbacks.


Copyright (c) 2015 Rakesh Ranjan singh, Ashmita Kiran, Anant Narayan Sinha

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Journal of Biology and Life Science  ISSN 2157-6076

Copyright © Macrothink Institute

To make sure that you can receive messages from us, please add the 'macrothink.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.

If you have questions, please contact jbls@macrothink.org.

------------------------------------------------------------------------------------------------------------------------------------------------------